Stay updated on EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.
Latest updates to the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page
- CheckyesterdayChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedSeveral key URLs related to genetics and drug information have been removed, along with participant and treatment details, while a 'Show less' option has been added.SummaryDifference4%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has added several new resources related to genetics and cancer treatments, including links to MedlinePlus and DailyMed, as well as new data fields for study information, while updating the revision from v2.12.1 to v2.12.2.SummaryDifference4%
- Check37 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
- Check66 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
Stay in the know with updates to EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.